Research strategy focuses on cancer evolution

Researchers at the ICR and The Royal Marsden are planning to create a new generation of ‘anti-evolution’ therapies designed to combat cancer’s ability to adapt and resist treatment, as part of their new joint research strategy

Our biggest challenge is cancer evolution and drug resistance